The Potent Humanin Analogue (HNG) Protects Germ Cells and Leucocytes While Enhancing Chemotherapy-Induced Suppression of Cancer Metastases in Male Mice

Overview

Journal Endocrinology

Publisher Oxford University Press

Specialty Endocrinology

Date 2015 Sep 19

PMID 26384090

Citations 21

Authors

Yanhe Lue

Ronald Swerdloff

Junxiang Wan

Jialin Xiao

Samuel French

Vince Atienza

Victor Canela

Kevin W Bruhn

Brian Stone

Yue Jia

Pinchas Cohen

Christina Wang

Affiliations

Soon will be listed here.

Abstract

Humanin is a peptide that is cytoprotective against stresses in many cell types. We investigated whether a potent humanin analogue S14G-humanin (HNG) would protect against chemotherapy-induced damage to normal cells without interfering with the chemotherapy-induced suppression of cancer cells. Young adult male mice were inoculated iv with murine melanoma cells. After 1 week, cancer-bearing mice were randomized to receive either: no treatment, daily ip injection of HNG, a single ip injection of cyclophosphamide (CP), or CP+HNG and killed at the end of 3 weeks. HNG rescued the CP-induced suppression of leucocytes and protected germ cell from CP-induced apoptosis. Lung metastases were suppressed by HNG or CP alone, and further suppressed by CP+HNG treatment. Plasma IGF-1 levels were suppressed by HNG with or without CP treatment. To investigate whether HNG maintains its protective effects on spermatogonial stem cells, sperm output, and peripheral leucocytes after repeated doses of CP, normal adult male mice received: no treatment, daily sc injection of HNG, 6 ip injections of CP at 5-day intervals, and the same regimens of CP+HNG and killed at the end of 4 weeks of treatment. Cauda epididymal sperm counts were elevated by HNG and suppressed by CP. HNG rescued the CP-induced suppression of spermatogonial stem cells, sperm count and peripheral leucocytes. We conclude that HNG 1) protects CP-induced loss of male germ cells and leucocytes, 2) enhances CP-induced suppression of cancer metastases, and 3) acts as a caloric-restriction mimetic by suppressing IGF-1 levels. Our findings suggest that humanin analogues may be promising adjuvants to chemotherapy.

Citing Articles

Humanin activates integrin αV-TGFβ axis and leads to glioblastoma progression.

Ha C, Hua T, Vo V, Om J, Han S, Cha S Cell Death Dis. 2024; 15(6):464.

PMID: 38942749 PMC: 11213926. DOI: 10.1038/s41419-024-06790-8.

Amyloid Beta Leads to Decreased Acetylcholine Levels and Non-Small Cell Lung Cancer Cell Survival via a Mechanism That Involves p38 Mitogen-Activated Protein Kinase and Protein Kinase C in a p53-Dependent and -Independent Manner.

Al Khashali H, Ray R, Darweesh B, Wozniak C, Haddad B, Goel S Int J Mol Sci. 2024; 25(9).

PMID: 38732252 PMC: 11084752. DOI: 10.3390/ijms25095033.

Neuroprotective Action of Humanin and Humanin Analogues: Research Findings and Perspectives.

Karachaliou C, Livaniou E Biology (Basel). 2023; 12(12).

PMID: 38132360 PMC: 10740898. DOI: 10.3390/biology12121534.

Mitochondrial Peptide Humanin Facilitates Chemoresistance in Glioblastoma Cells.

Pena Agudelo J, Pidre M, Garcia Fallit M, Perez Kuper M, Zuccato C, Nicola Candia A Cancers (Basel). 2023; 15(16).

PMID: 37627089 PMC: 10452904. DOI: 10.3390/cancers15164061.

Mitochondria-derived peptides in aging and healthspan.

Miller B, Kim S, Kumagai H, Yen K, Cohen P J Clin Invest. 2022; 132(9).

PMID: 35499074 PMC: 9057581. DOI: 10.1172/JCI158449.

References

Hoang P, Park P, Cobb L, Paharkova-Vatchkova V, Hakimi M, Cohen P . The neurosurvival factor Humanin inhibits beta-cell apoptosis via signal transducer and activator of transcription 3 activation and delays and ameliorates diabetes in nonobese diabetic mice. Metabolism. 2009; 59(3):343-9. PMC: 2932671. DOI: 10.1016/j.metabol.2009.08.001. View

Jia Y, Lue Y, Swerdloff R, Lee K, Cobb L, Cohen P . The cytoprotective peptide humanin is induced and neutralizes Bax after pro-apoptotic stress in the rat testis. Andrology. 2013; 1(4):651-9. PMC: 3696635. DOI: 10.1111/j.2047-2927.2013.00091.x. View

Gong Z, Tas E, Muzumdar R . Humanin and age-related diseases: a new link?. Front Endocrinol (Lausanne). 2014; 5:210. PMC: 4255622. DOI: 10.3389/fendo.2014.00210. View

Hashimoto Y, Suzuki H, Aiso S, Niikura T, Nishimoto I, Matsuoka M . Involvement of tyrosine kinases and STAT3 in Humanin-mediated neuroprotection. Life Sci. 2005; 77(24):3092-104. DOI: 10.1016/j.lfs.2005.03.031. View

Valdivieso M, Kujawa A, Jones T, Baker L . Cancer survivors in the United States: a review of the literature and a call to action. Int J Med Sci. 2012; 9(2):163-73. PMC: 3264952. DOI: 10.7150/ijms.3827. View

Guo B, Zhai D, Cabezas E, Welsh K, Nouraini S, Satterthwait A . Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature. 2003; 423(6938):456-61. DOI: 10.1038/nature01627. View

Capoluongo E . Insulin-like growth factor system and sporadic malignant melanoma. Am J Pathol. 2011; 178(1):26-31. PMC: 3069928. DOI: 10.1016/j.ajpath.2010.11.004. View

Muzumdar R, Huffman D, Atzmon G, Buettner C, Cobb L, Fishman S . Humanin: a novel central regulator of peripheral insulin action. PLoS One. 2009; 4(7):e6334. PMC: 2709436. DOI: 10.1371/journal.pone.0006334. View

Craft N, Bruhn K, Nguyen B, Prins R, Liau L, Collisson E . Bioluminescent imaging of melanoma in live mice. J Invest Dermatol. 2005; 125(1):159-165. PMC: 4141554. DOI: 10.1111/j.0022-202X.2005.23759.x. View

10.

Kopp L, Gupta P, Pelayo-Katsanis L, Wittman B, Katsanis E . Late effects in adult survivors of pediatric cancer: a guide for the primary care physician. Am J Med. 2012; 125(7):636-41. DOI: 10.1016/j.amjmed.2012.01.013. View

11.

Lue Y, Swerdloff R, Liu Q, Mehta H, Hikim A, Lee K . Opposing roles of insulin-like growth factor binding protein 3 and humanin in the regulation of testicular germ cell apoptosis. Endocrinology. 2009; 151(1):350-7. DOI: 10.1210/en.2009-0577. View

12.

Lee C, Yen K, Cohen P . Humanin: a harbinger of mitochondrial-derived peptides?. Trends Endocrinol Metab. 2013; 24(5):222-8. PMC: 3641182. DOI: 10.1016/j.tem.2013.01.005. View

13.

Drumond A, Weng C, Wang G, Chiarini-Garcia H, Eras-Garcia L, Meistrich M . Effects of multiple doses of cyclophosphamide on mouse testes: accessing the germ cells lost, and the functional damage of stem cells. Reprod Toxicol. 2011; 32(4):395-406. PMC: 3236636. DOI: 10.1016/j.reprotox.2011.09.010. View

14.

Tognon C, Sorensen P . Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy. Expert Opin Ther Targets. 2012; 16(1):33-48. DOI: 10.1517/14728222.2011.638626. View

15.

Arnaldez F, Helman L . Targeting the insulin growth factor receptor 1. Hematol Oncol Clin North Am. 2012; 26(3):527-42, vii-viii. PMC: 3334849. DOI: 10.1016/j.hoc.2012.01.004. View

16.

DAgostini C, Pica F, Febbraro G, Grelli S, Chiavaroli C, Garaci E . Antitumour effect of OM-174 and cyclophosphamide on murine B16 melanoma in different experimental conditions. Int Immunopharmacol. 2005; 5(7-8):1205-12. DOI: 10.1016/j.intimp.2005.02.013. View

17.

Lue Y, Wang C, Lydon J, Leung A, Li J, Swerdloff R . Functional role of progestin and the progesterone receptor in the suppression of spermatogenesis in rodents. Andrology. 2013; 1(2):308-17. DOI: 10.1111/j.2047-2927.2012.00047.x. View

18.

Yen K, Lee C, Mehta H, Cohen P . The emerging role of the mitochondrial-derived peptide humanin in stress resistance. J Mol Endocrinol. 2012; 50(1):R11-9. PMC: 3705736. DOI: 10.1530/JME-12-0203. View

19.

Jia Y, Ohanyan A, Lue Y, Swerdloff R, Liu P, Cohen P . The effects of humanin and its analogues on male germ cell apoptosis induced by chemotherapeutic drugs. Apoptosis. 2015; 20(4):551-61. PMC: 4351164. DOI: 10.1007/s10495-015-1105-5. View

20.

Eriksson E, Wickstrom M, Perup L, Johnsen J, Eksborg S, Kogner P . Protective role of humanin on bortezomib-induced bone growth impairment in anticancer treatment. J Natl Cancer Inst. 2014; 106(3):djt459. DOI: 10.1093/jnci/djt459. View